390 related articles for article (PubMed ID: 15233913)
1. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.
Liu J; Lillo C; Jonsson PA; Vande Velde C; Ward CM; Miller TM; Subramaniam JR; Rothstein JD; Marklund S; Andersen PM; Brännström T; Gredal O; Wong PC; Williams DS; Cleveland DW
Neuron; 2004 Jul; 43(1):5-17. PubMed ID: 15233913
[TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria.
Pasinelli P; Belford ME; Lennon N; Bacskai BJ; Hyman BT; Trotti D; Brown RH
Neuron; 2004 Jul; 43(1):19-30. PubMed ID: 15233914
[TBL] [Abstract][Full Text] [Related]
3. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS.
Higgins CM; Jung C; Ding H; Xu Z
J Neurosci; 2002 Mar; 22(6):RC215. PubMed ID: 11886899
[TBL] [Abstract][Full Text] [Related]
4. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
5. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes.
Higgins CM; Jung C; Xu Z
BMC Neurosci; 2003 Jul; 4():16. PubMed ID: 12864925
[TBL] [Abstract][Full Text] [Related]
6. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.
Audet JN; Gowing G; Julien JP
Neurobiol Dis; 2010 Oct; 40(1):245-50. PubMed ID: 20573565
[TBL] [Abstract][Full Text] [Related]
7. Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.
Zetterström P; Stewart HG; Bergemalm D; Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Oliveberg M; Marklund SL
Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14157-62. PubMed ID: 17715066
[TBL] [Abstract][Full Text] [Related]
8. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
9. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
[TBL] [Abstract][Full Text] [Related]
10. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice.
Tobisawa S; Hozumi Y; Arawaka S; Koyama S; Wada M; Nagai M; Aoki M; Itoyama Y; Goto K; Kato T
Biochem Biophys Res Commun; 2003 Apr; 303(2):496-503. PubMed ID: 12659845
[TBL] [Abstract][Full Text] [Related]
11. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
12. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
Zimmerman MC; Oberley LW; Flanagan SW
J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
[TBL] [Abstract][Full Text] [Related]
13. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria.
Vande Velde C; Miller TM; Cashman NR; Cleveland DW
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):4022-7. PubMed ID: 18296640
[TBL] [Abstract][Full Text] [Related]
14. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
15. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
[TBL] [Abstract][Full Text] [Related]
16. Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria.
Kawamata H; Manfredi G
Hum Mol Genet; 2008 Nov; 17(21):3303-17. PubMed ID: 18703498
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.
Israelson A; Ditsworth D; Sun S; Song S; Liang J; Hruska-Plochan M; McAlonis-Downes M; Abu-Hamad S; Zoltsman G; Shani T; Maldonado M; Bui A; Navarro M; Zhou H; Marsala M; Kaspar BK; Da Cruz S; Cleveland DW
Neuron; 2015 Apr; 86(1):218-32. PubMed ID: 25801706
[TBL] [Abstract][Full Text] [Related]
18. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS.
Urushitani M; Ezzi SA; Matsuo A; Tooyama I; Julien JP
FASEB J; 2008 Jul; 22(7):2476-87. PubMed ID: 18337461
[TBL] [Abstract][Full Text] [Related]
19. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
20. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
